Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors.
FOLFIRI
FOLFOX
antibody-dependent cell-mediated cytotoxicity
cetuximab
colorectal cancer
panitumumab
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
25
04
2019
accepted:
19
08
2019
entrez:
17
10
2019
pubmed:
17
10
2019
medline:
17
10
2019
Statut:
epublish
Résumé
Cetuximab and panitumumab are two distinct monoclonal antibodies (mAbs) targeting the epidermal growth factor receptor (EGFR), and both are widely used in combination with chemotherapy or as monotherapy to treat patients with
Identifiants
pubmed: 31616627
doi: 10.3389/fonc.2019.00849
pmc: PMC6763619
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
849Informations de copyright
Copyright © 2019 García-Foncillas, Sunakawa, Aderka, Wainberg, Ronga, Witzler and Stintzing.
Références
Future Oncol. 2015;11(4):629-40
pubmed: 25686118
Clin Cancer Res. 2015 May 1;21(9):2157-66
pubmed: 25623215
Cancer Immunol Res. 2016 Apr;4(4):366-74
pubmed: 26817995
Hematol Oncol Clin North Am. 2015 Dec;29(6):1033-43
pubmed: 26568546
J Immunother. 2012 Jun;35(5):440-7
pubmed: 22576349
Lancet Oncol. 2013 Jul;14(8):697-710
pubmed: 23746666
Mol Cancer Ther. 2012 Jul;11(7):1467-76
pubmed: 22564724
Nat Med. 2016 Jun;22(6):624-31
pubmed: 27135741
Cancer Chemother Pharmacol. 2010 Aug;66(3):605-9
pubmed: 20361188
PLoS One. 2013 Aug 21;8(8):e71703
pubmed: 23990977
Clin Cancer Res. 2012 Jan 15;18(2):432-41
pubmed: 22090361
Int J Cancer. 2015 Feb 15;136(4):821-30
pubmed: 24947844
JAMA. 2017 Jun 20;317(23):2392-2401
pubmed: 28632865
Lancet Oncol. 2016 Oct;17(10):1426-1434
pubmed: 27575024
Lancet Oncol. 2015 Feb;16(2):221-32
pubmed: 25596659
J Cancer Res Clin Oncol. 2012 Jan;138(1):65-72
pubmed: 21960318
Ann Oncol. 2013 Aug;24(8):2062-7
pubmed: 23666916
Lancet Oncol. 2010 Aug;11(8):753-62
pubmed: 20619739
N Engl J Med. 2008 Oct 23;359(17):1757-65
pubmed: 18946061
Cancer Immunol Immunother. 2017 May;66(5):573-579
pubmed: 28197666
Ann Oncol. 2017 Aug 01;28(8):1713-1729
pubmed: 28407110
Clin Cancer Res. 2013 Apr 1;19(7):1858-72
pubmed: 23444227
BMC Cancer. 2015 Oct 16;15:713
pubmed: 26474549
Clin Cancer Res. 2013 Apr 1;19(7):1902-12
pubmed: 23325582
Ann Oncol. 2013 Feb;24(2):412-419
pubmed: 23041588
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Oncology. 2018;94(4):191-199
pubmed: 29393280
J Clin Oncol. 2015 Mar 1;33(7):692-700
pubmed: 25605843
Ann Oncol. 2014 Jan;25(1):107-16
pubmed: 24356622
J Natl Compr Canc Netw. 2009 Sep;7(8):778-831
pubmed: 19755046
Br J Cancer. 2012 Dec 4;107(12):1932-7
pubmed: 23169296
Cancer Immunol Immunother. 2009 Nov;58(11):1853-64
pubmed: 19319529
Science. 2014 Mar 14;343(6176):1260-3
pubmed: 24626930
Cancer Discov. 2014 May;4(5):522-6
pubmed: 24795012
Clin Cancer Res. 2017 Feb 1;23(3):707-716
pubmed: 27496866
Ann Oncol. 2014 Jul;25(7):1346-1355
pubmed: 24718886
Jpn J Clin Oncol. 2016 Mar;46(3):228-33
pubmed: 26759349
Cancer Sci. 2013 Apr;104(4):473-80
pubmed: 23298313
Nat Med. 2014 Jun;20(6):607-15
pubmed: 24793239
Cancer Sci. 2017 Mar;108(3):455-460
pubmed: 28075526
Clin Cancer Res. 2014 Jun 1;20(11):2831-7
pubmed: 24879823
Nat Med. 2012 Jan 22;18(2):221-3
pubmed: 22270724
Cancer Immunol Res. 2015 Aug;3(8):936-45
pubmed: 25972070
Cancer Discov. 2014 Nov;4(11):1269-80
pubmed: 25293556
Nat Med. 2015 Jul;21(7):827
pubmed: 26151329
Cancer Chemother Pharmacol. 2018 Jan;81(1):179-182
pubmed: 29170802
Oncologist. 2015 Apr;20(4):411-32
pubmed: 25765877
Eur J Cancer. 2017 Aug;81:191-202
pubmed: 28633089
N Engl J Med. 2008 Sep 11;359(11):1116-27
pubmed: 18784101
PLoS One. 2015 Aug 14;10(8):e0135673
pubmed: 26273837
Mol Cancer Ther. 2002 May;1(7):507-14
pubmed: 12479268
Lancet. 2011 Jun 18;377(9783):2103-14
pubmed: 21641636
Exp Mol Med. 2011 Oct 31;43(10):539-49
pubmed: 21811090
Oncol Lett. 2016 Jun;11(6):4049-4054
pubmed: 27313739
Nat Rev Immunol. 2011 Sep 23;11(10):702-11
pubmed: 21941296
Eur J Cancer. 2016 Nov;68:51-59
pubmed: 27716478
Ann Oncol. 2010 Jul;21(7):1537-1545
pubmed: 19940007
J Immunother. 2009 Jun;32(5):465-73
pubmed: 19609238
Cancer Chemother Pharmacol. 2011 Oct;68(4):871-8
pubmed: 21286718
J Clin Invest. 2014 Jun;124(6):2668-82
pubmed: 24837434
Neoplasia. 2012 Nov;14(11):1023-31
pubmed: 23226096
Oncology. 2013;84(5):273-83
pubmed: 23445638
JAMA Oncol. 2018 Apr 01;4(4):529-536
pubmed: 29450468
PLoS One. 2007 Mar 28;2(3):e326
pubmed: 17389917
Clin Cancer Res. 2016 Jul 1;22(13):3260-7
pubmed: 26888827
Crit Rev Oncol Hematol. 2015 Aug;95(2):179-90
pubmed: 25819749
Ann Oncol. 2006 May;17(5):835-41
pubmed: 16507564
J Clin Oncol. 2008 Nov 20;26(33):5335-43
pubmed: 18854570
Ann Oncol. 2017 Aug 1;28(8):2030-2031
pubmed: 28475674
Clin Cancer Res. 1999 Feb;5(2):257-65
pubmed: 10037173
Oncotarget. 2016 Dec 27;7(52):86359-86373
pubmed: 27861156
Cancer Res. 2010 Apr 15;70(8):3052-61
pubmed: 20388795
Immunity. 2016 Feb 16;44(2):343-54
pubmed: 26872698
Nature. 2012 Jun 28;486(7404):532-6
pubmed: 22722830
Oncologist. 2008 Jan;13(1):39-50
pubmed: 18245011
Clin Transl Oncol. 2013 Sep;15(9):705-11
pubmed: 23359181
Expert Opin Drug Metab Toxicol. 2015;11(12):1907-24
pubmed: 26572750
Immunol Res. 2011 Aug;50(2-3):248-54
pubmed: 21717064
PLoS One. 2016 Sep 22;11(9):e0163366
pubmed: 27658254
J Clin Oncol. 2012 Aug 10;30(23):2861-8
pubmed: 22753904
Clin Colorectal Cancer. 2010 Dec;9(5):282-9
pubmed: 21208842
J BUON. 2016 Jan-Feb;21(1):70-9
pubmed: 27061533
Oncoimmunology. 2017 Oct 4;6(12):e1386829
pubmed: 29209573
Cancer Res. 2007 Sep 1;67(17):8240-7
pubmed: 17804738
Clin Colorectal Cancer. 2015 Jun;14(2):81-90
pubmed: 25666296
Cancer Res. 2008 Jul 1;68(13):4998-5003
pubmed: 18593896
Ann Oncol. 2005 May;16 Suppl 4:iv61-68
pubmed: 15923432
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
J Clin Oncol. 2014 Jul 20;32(21):2240-7
pubmed: 24687833
Biochem Biophys Res Commun. 2017 May 20;487(1):1-7
pubmed: 28042031
J Clin Oncol. 1998 Aug;16(8):2825-33
pubmed: 9704735
Anticancer Res. 2016 Sep;36(9):4421-6
pubmed: 27630277
Clin Cancer Res. 2016 Nov 1;22(21):5229-5237
pubmed: 27217441
Nat Commun. 2016 Dec 08;7:13665
pubmed: 27929064
Blood. 2007 Oct 1;110(7):2561-4
pubmed: 17475906
Oncotarget. 2015 May 20;6(14):12035-47
pubmed: 26059438
World J Gastroenterol. 2011 Apr 14;17(14):1879-88
pubmed: 21528063
Dis Colon Rectum. 2010 Jan;53(1):57-64
pubmed: 20010352
Ann Oncol. 2015 Jan;26(1):40-47
pubmed: 24997207
Int J Cancer. 2012 Apr 1;130(7):1577-89
pubmed: 21618510
Ann Oncol. 2012 Sep;23(9):2313-2318
pubmed: 22396447
J Clin Oncol. 2009 Feb 10;27(5):663-71
pubmed: 19114683
Oncol Lett. 2016 Sep;12(3):1868-1876
pubmed: 27602116
Contemp Oncol (Pozn). 2014;18(1):7-16
pubmed: 24876815
Biologics. 2008 Jun;2(2):223-8
pubmed: 19707356
J Clin Oncol. 2018 Oct 20;36(30):3031-3039
pubmed: 30199311
Ann Oncol. 2017 Aug 01;28(8):1862-1868
pubmed: 28449055
Jpn J Clin Oncol. 2013 Nov;43(11):1080-6
pubmed: 23999770
JAMA Oncol. 2017 Feb 01;3(2):194-201
pubmed: 27722750
Expert Rev Anticancer Ther. 2007 Apr;7(4):407-13
pubmed: 17428161
Eur J Cancer. 2015 Jul;51(10):1243-52
pubmed: 25937522
Ann Oncol. 2010 May;21 Suppl 5:v184-6
pubmed: 20555077
Cancer Treat Rev. 2018 Feb;63:48-60
pubmed: 29223828
Oncoimmunology. 2016 Aug 03;5(8):e1192739
pubmed: 27622063
Anticancer Res. 2011 Dec;31(12):4569-74
pubmed: 22199332
N Engl J Med. 2006 Feb 9;354(6):567-78
pubmed: 16467544
Clin Colorectal Cancer. 2016 Dec;15(4):285-291
pubmed: 27553906
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839